Comparison of circulating tumor cell numbers before and after treatment is predictive for overall survival in patients with metastatic castration-resistant prostate cancer; this comparison is more helpful than prostate-specific antigen detection, according to a recent study.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery
BMC Cancer Open Access 16 November 2012
-
Perioperative cancer cell dissemination detected with a real-time RT-PCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarcinoma
BMC Cancer Open Access 31 January 2011
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
de Bono, J. S. et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin. Cancer Res. 14, 6302–6309 (2008).
Pantel, K., Brakenhoff, R. H. & Brandt, B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat. Rev. Cancer 8, 329–340 (2008).
Okegawa, T., Nutahara, K. & Higashihara, E. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer. J. Urol. 180, 1342–1347 (2008).
Danila, D. C. et al. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin. Cancer Res. 13, 7053–7058 (2007).
Ross, R. W. et al. Prognostic significance of baseline reverse transcriptase-PCR for prostate-specific antigen in men with hormone-refractory prostate cancer treated with chemotherapy. Clin. Cancer Res. 11, 5195–5198 (2005).
Ghossein, R. A. et al. Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma. Urology 50, 100–105 (1997).
Allard, W. J. et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer Res. 10, 6897–6904 (2004).
de Bono, J. S. et al. Potential applications for circulating tumor cells expressing the insulin-like growth factor-I receptor. Clin. Cancer Res. 13, 3611–3616 (2007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Pantel, K., Riethdorf, S. Are circulating tumor cells predictive of overall survival?. Nat Rev Clin Oncol 6, 190–191 (2009). https://doi.org/10.1038/nrclinonc.2009.23
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2009.23
This article is cited by
-
Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device
Nature Protocols (2018)
-
Hallmarks of Bone Metastasis
Calcified Tissue International (2018)
-
Improving particle detection sensitivity of a microfluidic resistive pulse sensor by a novel electrokinetic flow focusing method
Microfluidics and Nanofluidics (2017)
-
Circulating tumor cells in breast cancer and its association with tumor clinicopathological characteristics: a meta-analysis
Medical Oncology (2014)
-
Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery
BMC Cancer (2012)
